Should Infants Continue Nebulizer Treatment After Pneumonia Treatment and the Issue of Vaccination

A 63-day-old infant was hospitalized for bronchopneumonia and received nebulizer treatment daily for 5 days. After discharge, the infant continued with nebulizer treatment for 18 more days. Now, the cough has mostly subsided, and nasal discharge has decreased. Questions are raised about whether to continue the nebulizer treatment and whether it’s safe to replace the ipratropium bromide suspension with 2 ml of normal saline, alternating with budesonide suspension for inhalation. Additionally, the infant has only received the second dose of the hepatitis B vaccine, and the third doses of BCG and hepatitis B vaccine were supposed to be administered at one month of age but have not been yet. Concerns are raised about the potential impact.
2 minutes to read